The Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure

This study has been completed.
Sponsor:
Information provided by:
Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT01029860
First received: December 9, 2009
Last updated: December 16, 2009
Last verified: March 2007
  Purpose

The purpose of this study is to assess the effect of hospital admission on 24-hour ambulatory blood pressure (ABP) in hypertensive subjects.Treated or untreated hypertensive adults with open angle glaucoma underwent in-hospital and outpatient 24-hour ABP monitoring, in random order 4 weeks apart.


Condition
Blood Pressure

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: A Study Investigating the Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure in Subjects With Mild to Moderate Arterial Hypertension and Untreated Ocular Hypertension

Resource links provided by NLM:


Further study details as provided by Aristotle University Of Thessaloniki:

Enrollment: 40
Study Start Date: March 2007
Study Completion Date: March 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   30 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Subjects with untreated ocular hypertension and stage 1 arterial hypertension with or without treatment with anti-hypertensive agents.

Criteria

Inclusion Criteria:

  • age >30 years old.
  • subject has signed an informed consent.
  • patient has untreated ocular hypertension (IOP at 10:00 between 22-34 mm Hg)
  • patient has stage 1 arterial hypertension with or without therapy

Exclusion Criteria:

  • secondary hypertension.
  • stage 2 or 3 hypertension, history of renal disease.
  • sleep apnea.
  • diabetes mellitus
  • acute or chronic inflammation.
  • myocardial infarction or unstable angina within the past 6 months.
  • heart failure NYHA class III-IV.
  • active liver disease.
  • pregnancy.
  • history of drug or alcohol abuse, or any other condition with poor prognosis.
  • treatment with non-steroid anti-inflammatory agents, corticosteroids, beta-blockers, or any other regimen that could affect BP levels.
  • smoking
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Anastasios Lasaridis, 1st Department of Internal Medicine, Aristotle University, Thessaloniki
ClinicalTrials.gov Identifier: NCT01029860     History of Changes
Other Study ID Numbers: A3244
Study First Received: December 9, 2009
Last Updated: December 16, 2009
Health Authority: Greece: Ethics Committee

Keywords provided by Aristotle University Of Thessaloniki:
Hypertension
Ambulatory measurement

Additional relevant MeSH terms:
Hypertension
Ocular Hypertension
Vascular Diseases
Cardiovascular Diseases
Eye Diseases

ClinicalTrials.gov processed this record on April 16, 2014